Medical Writer & Regulatory Manager. OxThera. aug 2019 –nu1 år 8 månader. Stockholm, Sweden. My current role
View Ron Weaver’s profile on LinkedIn, the world's largest professional community. Ron has 1 job listed on their profile. See the complete profile on LinkedIn and discover Ron’s connections
Curren tly pharmaceutical treatment is not available and median age of death is 30. View Tracy Deson’s profile on LinkedIn, the world’s largest professional community. Tracy has 7 jobs listed on their profile. See the complete profile on LinkedIn and discover Tracy’s OxThera utvecklar en ny behandling, Oxabact®, för primär hyperoxaluri (PH), en allvarlig och ofta dödlig sjukdom hos barn, och där det för närvarande inte finns några tillgängliga behandlingar. Företaget är redo att initiera en avgörande fas III-studie av PH med Oxabact® för att stoppa och/eller fördröja sjukdomsprogressionen. Proff.se ger dig företagsinformation om OxThera AB, 556681-5667. Hitta adress på karta, kontaktinfo, nyckeltal och befattningar.
Läkemedelsmarknaden – Doctare.se OxThera AB, LTB4 Sweden AB och Nordic Nanovector AS. Oberoende i Se Bravo Eduardos profil på LinkedIn, världens största yrkesnätverk. Kontakt. Elin Westin, Kommunikationsdirektör. Elin Westin Kommunikationsdirektör +46 702 777 526 · Facebook LinkedIn Twitter E-mail Print Kirsti Gjellan - Board Director - OxThera | LinkedIn.
Liknande sidor.
LinkedIn is a social network for professionals to connect, share, and learn. If you're searching for a job, LinkedIn is a must-have resource. Here's what you need to know. LinkedIn is a social network for professionals to connect, share, an
Martijn's prime focus and responsibility within LSP is to invest in unlisted securities and the general management of the firm. Prior to establishing LSP, Se Sten Verland, PhD MScs profil på LinkedIn – verdens største faglige netværk. Sten har 25 job på sin profil.
Oxthera develops a novel treatment for patients with the ultra-orphan kidney disease primary hyperoxaluria. In patients, mostly children, this life-threatening disease accumulates oxalate in the body and the oxalate forms insoluble crystals and stones in different organs (kidney, liver, heart and eyes).
2019-11-07 View Harmeet Sidhu’s profile on LinkedIn, the world's largest professional community. Harmeet has 3 jobs listed on their profile. See the complete profile on LinkedIn and discover Harmeet’s Oxthera utvecklar ny behandling för patienter med den livshotande njursjukdomen primär hyperoxaluri.
New OxThera/Oxabact US patent granted 2021-02-25. Stockholm – 25 February 2021. OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces that a new US patent has been granted for its product candidate Oxabact announces that a new US patent has been granted for its product candidate Oxabact, and for a method
Se Elisabeth Lindners profil på LinkedIn, världens största yrkesnätverk. Elisabeth har angett 9 jobb i sin profil.
Julbord borlange
Se Bo Ahlstrands profil på LinkedIn, världens största yrkesnätverk. Bo har angett 9 jobb i sin profil. Se hela profilen på LinkedIn, se Bos kontakter och hitta jobb på liknande företag. Sehen Sie sich das Profil von Bastian Dehmel, MD im größten Business-Netzwerk der Welt an.
Sök efter Maria på LinkedIn
Links to.
Anna strömberg egenvård
bachelor betyder på svenska
hoftled engelska
geovetare
agile rup vs scrum
Phone: +46 70 879 19 37. Email: jonas.brambeck@industrifonden.com. Involved in: Athera Oncopeptides OxThera. Twitter Crunchbase. Jonas Brambeck has been working in Industrifonden’s Life Science team since 1998 and has lead a number of investments in pharma and diagnostics.
See the complete profile on LinkedIn and discover Tracy’s "OxThera is a spin-out company from Q-Med AB. OxThera develops products using its cell- and enzyme-based proprietary technologies for metabolic disorders based on excess oxalate, a … STOCKHOLM, November 15, 2018 /PRNewswire/ --. OxThera AB, a privately-held Stockholm-based biopharmaceutical company, today announced a granted US patent on Oxalobacter formigenes secretagogues.. Oxabact ®, a formulation of highly concentrated lyophilized Oxalobacter formigenes, is being developed by OxThera AB as a potential treatment for patients with primary hyperoxaluria (PH). Oxthera utvecklar ny behandling för patienter med den livshotande njursjukdomen primär hyperoxaluri.
Sehen Sie sich das Profil von Bastian Dehmel, MD im größten Business-Netzwerk der Welt an. Im Profil von Bastian Dehmel, MD sind 6 Jobs angegeben. Auf LinkedIn können Sie sich das vollständige Profil ansehen und mehr über die Kontakte von Bastian Dehmel, MD und Jobs bei ähnlichen Unternehmen erfahren.
20 Apr 2021 Gantz was most recently CEO of OxThera AB, a biopharmaceutical company based in Sweden.
Se hela profilen på LinkedIn, se Elisabeths kontakter och hitta jobb på liknande företag.